Oral Vancomycin Induces and Maintains Remission of Ulcerative Colitis in the Subset of Patients With Associated Primary Sclerosing Cholangitis-Reference-Cited by-同舟云学术

Oral Vancomycin Induces and Maintains Remission of Ulcerative Colitis in the Subset of Patients With Associated Primary Sclerosing Cholangitis

Published:2019-03-06 Issue:7 Volume:25 Page:e90-e91
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Dao Alexander¹^ORCID,Abidian Mohamed¹,Lestrange Aimee¹,Mattar Mark¹,Rangnekar Amol¹,Charabaty Aline²

Affiliation:

1. Department of Gastroenterology, Georgetown University Hospital, Washington, DC

2. Department of Gastroenterology, Johns Hopkins School of Medicine, Washington, DC

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

http://academic.oup.com/ibdjournal/article-pdf/25/7/e90/28873352/izz027.pdf

Reference3 articles.

1. Hawkins M , ShettyK, LandsmanM, et al Inflammatory bowel disease following liver transplantation: incidence of active disease and risk factors for de novo disease and for increase in disease severity. Poster presented at: Digestive Disease Week; May 18–21, 2013; Orlando, FL.

2. Immunomodulatory effect of vancomycin on treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis;Abarbanel;J Clin Immunol.,2013

3. Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study;Tabibian;Aliment Pharmacol Ther.,2013

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis‐associated inflammatory bowel disease?;Alimentary Pharmacology & Therapeutics;2024-04-23

2. Coexisting Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Overlapping Challenges in Diagnosis and Treatment;Case Reports in Gastroenterology;2024-03-26

3. Safety and Effectiveness of Janus Kinase Inhibitors in the Management of Inflammatory Bowel Disease Following Liver Transplantation;Journal of Crohn's and Colitis;2024-03-19

4. Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (PSC‐IBD): A matched analysis from the Paediatric PSC Consortium;Alimentary Pharmacology & Therapeutics;2024-03-10

5. Vancomycin and Ustekinumab Combination Therapy in Acute Ulcerative Colitis;ACG Case Reports Journal;2024-03